News

22
Jun

CATALIS is now implementing its new strategic plan with the creation of new advisory committees

CATALIS is now implementing its new strategic plan with the creation of new advisory committees Since 2018, CATALIS’s operational activities have been guided essentially by an advisory committee composed of research centre administrators, pharmaceutical industry members, and government representatives. In 2021, given that the new strategic plan extends the scope of CATALIS’s actions, two new advisory committees will be created: a

Read more

19
May

CATALIS has great plans for the coming year.

CATALIS has great plans for the coming year. A message from the chairman of the CATALIS board of directors, Dr. Marc Rivière There is no doubt that this past year has been disconcerting and most unusual. Clinical research was confronted with substantial challenges that highlighted our system’s ability to adapt quickly and find innovative solutions. This exceptional situation caused us to

Read more

19
May

Boehringer Ingelheim and Sanofi Join the CATALIS Network

Boehringer Ingelheim and Sanofi Join the CATALIS Network New pharmaceutical industry partners are supporting CATALIS in making Quebec a world leader in clinical research. MONTREAL, May 20, 2021 —CATALIS Québec is proud to announce that two pharmaceutical companies, Boehringer Ingelheim and Sanofi, have joined its network of partners who are working together to support Quebec’s competitiveness in conducting clinical trials.

Read more

15
Feb

Diffusion of the updated “Standard legal clauses for information and consent forms for clinical trials”

Diffusion of the updated “Standard legal clauses for information and consent forms for clinical trials” CATALIS Québec is pleased to announce that the revised version of the “Standard legal clauses for information and consent forms for clinical trials” has been published by the ministry of health and social services (MSSS). The original legal clauses for consent forms, published in 2016

Read more

18
Jan

CATALIS Quebec announces the rolls out the 2nd phase of Nagano clinical trial evaluation management system synchronization in the Quebec’s health and social services institutions

CATALIS Quebec announces the rolls out the 2nd phase of Nagano clinical trial evaluation management system synchronization in the Quebec’s health and social services institutions Since 2010, majority of public institutions in Quebec’s health and social services network have gradually integrated the Nagano computer system, a platform that makes the administrative management of research projects, including clinical trials’ evaluation and

Read more

9
Jun

Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President

Appointment of Jacques Hendlisz as CATALIS Québec’s New Executive President CATALIS Quebec is proud to welcome Mr. Jacques Hendlisz to the organization as its new Executive President, effective April 1, 2020. Mr. Hendlisz is widely recognized for his extensive experience in the management of both research and hospital facilities. He served as the Douglas Institute’s Director General from 1994 to

Read more

11
Mar

CATALIS Québec applauds the Quebec Government’s commitment to clinical research

The Quebec Government’s 2020–2021 budget, tabled yesterday by Minister of Finance Éric Girard, mentions investments in the field of clinical research, a commitment that was favourably received by CATALIS Québec’s board of directors.

17
Oct

PRESS RELEASE : The smart choice in early-stage clinical research

CATALIS Québec launches a promotional campaign to demonstrate Quebec’s expertise in the conduct of early-phase clinical trials and to encourage new partnerships between the biopharmaceutical industry and university research centres.

3
Jun

Pharmaceutical Industry Invests in the Development of Early Clinical Research in Quebec

CATALIS’s public and private partners join forces to make Quebec a global leader in the conduct of early-stage clinical trials.

19
Mar

Pooling Quebec’s clinical research resources to provide better patient care

How to propel Quebec to global leadership in early clinical research? Dr. Marc Rivière, the new chair of the board of directors of CATALIS Quebec, shares his vision.